Elastases are a type of serine proteases produced by the pancreas. Elastase catalyzes the cleavage of carboxyl groups present in small hydrophobic amino acids such as glycine, alanine and valine. Its main role is to break down elastin, a protein that imparts elasticity to connective tissue. Elastase not only cleaves the important connective tissue protein elastin, but also promotes the degradation of extracellular matrix such as fibronectin; laminin; collagens III, IV and VI; and proteoglycans. Activation of elastase-type serine proteases can lead to acute pancreatitis, chronic inflammatory lung disease, and cancer. Mammalian elastase occurs mainly in the pancreas and phagocytes. Among non-mammalian elastases, there are a variety of bacterial metallo and serine elastases. Elastolytic activity varies from elastase to elastase and is usually independent of the catalytic efficiency of these proteases. A large number of natural (protein) and synthetic elastase inhibitors are available. Elastases play a pathological role in emphysema, cystic fibrosis, infections, inflammation and atherosclerosis.
BOC Sciences can produce 500 potential elastase inhibitors via establishing an elastase serine protease targeted library.
Figure 1. Design of ultrasensitive probes for human neutrophil elastase. (Kasperkiewicz, P.; et al. 2014)
BOC Sciences has developed a receptor-based library of potential elastase serine protease inhibitors by employing docking approach.
BOC Sciences provides professional, rapid and high-quality services of Elastase Serine Protease Targeted Library design at competitive prices for global customers. Personalized and customized services of Elastase Serine Protease Targeted Library design can satisfy any innovative scientific study demands. Our clients have direct access to our staff and prompt feedback to their inquiries. If you are interested in our services, please contact us immediately!
Reference
BOC Sciences has rich experience in working with global customers in custom library synthesis of compounds and generating small to medium-sized libraries of target compounds. Our knowledge in generating a large number of target molecules in a remarkably shorter time enables quick biological screenings for affinities. With the target properties in mind, we deliver target molecules, by applying our extensive knowledge in drug discovery.